ArticleMolecular pharmaceutics2020

Cellular Delivery of Bioorthogonal Pretargeting Therapeutics in PSMA-Positive Prostate Cancer.

Sudath Hapuarachchige et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.